← Back to Search

Behavioural Intervention

Non-Invasive Vibration Therapy for Parkinson's Disease

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

This trial will test a non-invasive device to reduce Parkinson's symptoms. Patients will be monitored for two years to see if the device works.

Who is the study for?
This trial is for people aged 35-90 with advanced Parkinson's Disease (stages 2 to 4), who are comfortable with technology and can manage without certain brain function medications during EEG recordings. They must not be pregnant, involved in other trials recently, have a history of significant brain surgery or severe psychiatric issues, or substance abuse problems.Check my eligibility
What is being tested?
The study tests Vibrotactile Coordinated Reset stimulation using the vibrotactile axon Glove on Parkinson's symptoms. It offers a non-invasive treatment alternative to levodopa or deep brain stimulation and monitors patients over two years.See study design
What are the potential side effects?
Potential side effects aren't specified but as vCR is non-invasive and doesn't involve drugs, it may be associated with less risk than medication or surgical options. However, discomfort from glove use or skin irritation could occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III change from baseline, 6 months, 12 months, 18 months and 24 months, while patients are examined off medication)
Secondary outcome measures
Communicative Participation Item Bank (CPIB; Short Form) change from baseline, 6 months, 12 months, 18 months and 24 months.
Freezing of Gait Questionnaire (FOG) change from baseline, 6 months, 12 months, 18 months and 24 months.
Levodopa equivalent daily dose (LEDD) daily change from baseline to 24 months
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Vibrotactile Coordinated Reset (vCR)Experimental Treatment1 Intervention
Vibrotactile Coordinated Reset delivers vibratory stimulation to the fingertips of each hand. A specific pattern of vibration to each fingertip is delivered which theoretically disrupts abnormal synchrony in the brain.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,998 Total Patients Enrolled

Media Library

Vibrotactile Coordinated Reset (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05504902 — N/A
Parkinson's Disease Research Study Groups: Vibrotactile Coordinated Reset (vCR)
Parkinson's Disease Clinical Trial 2023: Vibrotactile Coordinated Reset Highlights & Side Effects. Trial Name: NCT05504902 — N/A
Vibrotactile Coordinated Reset (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05504902 — N/A
Parkinson's Disease Patient Testimony for trial: Trial Name: NCT05504902 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom does eligibility for this experiment extend?

"To qualify for this trial, participants must have a diagnosis of Parkinson's disease and be between 35 to 90 years old. Currently, 10 people are being enrolled into the study."

Answered by AI

Are participants still being accepted into this experiment?

"Per the information on clinicaltrials.gov, enrollment for this medical trial has been suspended since October 24th 2022 and is not presently accepting candidates; however, 488 other studies are actively recruiting patients currently."

Answered by AI

Are individuals aged 35 or above being included as participants in this research?

"The patient pool for this medical trial spans from 35 to 90 years of age."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
California
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
1

Why did patients apply to this trial?

I saw the story on the Today show and I have been diagnosed with PD. I was diagnosed in 2020, Left-hand tremor is the only symptom so far. I feel this might work for me.
PatientReceived 2+ prior treatments
I saw the piece on the Today show and the gloves that were used to treat some of the symptoms and they're compelling. My main issues: 1) my balance and gate are poor (lightheadedness).
PatientReceived 1 prior treatment
I saw the piece on the Today show and the gloves that were used to treat some of the symptoms and they're compelling. My main issues: 1) my balance and gate are poor (lightheadedness). Consistent day to day sleep, executive function and my speech.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

I was diagnosed in 2020, Left-hand tremor is the only symptom so far. Could this be my solution?
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Vibrotactile Coordinated Reset for the Treatment of Advanced Parkinson's Disease
Peter Tass, MD, PhD 2023. "Vibrotactile Coordinated Reset for the Treatment of Advanced Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05504902.
~7 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top